News About: Med. Insurance
Korea should redefine optimization of medication costsThe Korean government needs to investigate ever-increasing medication costs as part of efforts to understand their optimization size, according to a local professor.
Professo... |
Positive list system is still under heated debate
The government is likely to push up with the plan to evaluate the economic effectiveness of conventional medicines based on its own assessment criteria.
In a recent forum on September 19, officials from the Health ...
KRPIA calls for more objective evaluation criteria on medicinesThe Korea Research-based Pharmaceutical Industry Association (KRPIA) reclaimed that health authorities need to establish more transparent and objective guidelines in assessing t... |
Health ministry to get tough over generic data fabrication
Drug makers who are found to market any generic drugs whose bioequivalence testing was falsified after getting into the national health insurance will be subject to a heavy fine, five times as high as revenues, accord...
Health insurance covers additional indications of Lyrica
Pfizer Korea says the national health insurance has covered the additional indications of anticonvulsant drug Lyrica (pregabalin), such as neuropathic pain after spinal cord injury and complex regional pain syndrome (...
Hospital overcharges W5.8 billion won
Patients will receive about 5.8 billion won in medical fee refunds because some hospitals overcharged for health insurance coverage, health authorities said on September 8.
The Health Insurance Review & Assessment...
Patients to benefit from homegrown Peluvi tablet
The National Health Insurance Corporation and Daewon Pharm finally agreed on September 3 to set the insurance price of Peluvi (felubiprofen) at 208 won per tablet.
Daewon demanded the government set a minimum price...
3,729 items to be re-evaluated over economic effectiveness
The Health Insurance Review and Assess Service (HIRA) announced on September 2 that a total of 3,729 items from six therapeutic categories will be evaluated for their economic effectiveness within this year.
The si...
Government to streamline drug pricing policy
OTC products to be deleted from health insurance eligible category will be carefully selected to prevent “drug shift phenomenon”, according to the Ministry of Health, Welfare and Family Affairs.
In a recent forum, ...
Yungjin, Ildong face redemption suit of medication costs
The National Health Insurance Corporation filed a suit against Yungjin Pharm and Ildong Pharm, for their improper health insurance allowance claim of medicines involved in fabricated bioequivalence test results.
“T...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
30 | 31 | 1 | 2 | 3 | 4 | 5 |
6 | 7 | 8 | 9 | 10 | 11 | 12 |
13 | 14 | 15 | 16 | 17 | 18 | 19 |
20 | 21 | 22 | 23 | 24 | 25 | 26 |
27 | 28 | 29 | 30 | 1 | 2 | 3 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
